Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00862303
What this trial is testing

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fuzhou General Hospital 100
Testing effectiveness (Phase 2)UnknownNCT02809092
What this trial is testing

Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hospital de Clinicas de Porto Alegre 30
Testing effectiveness (Phase 2)UnknownNCT05108077
What this trial is testing

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Who this might be right for
Bladder CancerRenal Cancer
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Early research (Phase 1)Temporarily pausedNCT06677710
What this trial is testing

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisPrimary Progressive Multiple Sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)+8 more
Indapta Therapeutics, INC. 34
Early research (Phase 1)Study completedNCT03941262
What this trial is testing

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

Who this might be right for
Refractory CancerMetastatic CancerRecurrent Cancer+4 more
NKGen Biotech, Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Not applicableUnknownNCT01915992
What this trial is testing

Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies

Who this might be right for
Leukemia
Assistance Publique Hopitaux De Marseille 15
Not applicableEnded earlyNCT03242265
What this trial is testing

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy

Who this might be right for
Immunity, InnateProstatic Neoplasm
ATGen Canada Inc 84
Early research (Phase 1)Active Not RecruitingNCT04623944
What this trial is testing

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

Who this might be right for
Relapsed/Refractory AMLAML, AdultMDS+1 more
Nkarta, Inc. 61
Early research (Phase 1)UnknownNCT02961712
What this trial is testing

Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)

Who this might be right for
HAM
The Second Affiliated Hospital of Fujian Medical University 15
Testing effectiveness (Phase 2)Looking for participantsNCT05580601
What this trial is testing

Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Children's Hospital Medical Center, Cincinnati 20
Testing effectiveness (Phase 2)UnknownNCT04872634
What this trial is testing

Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment

Who this might be right for
Non-small Cell Lung Cancer
NKMAX Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03595657
What this trial is testing

CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma
CStone Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT01894373
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Who this might be right for
PsoriasisAdoptive Immunotherapy
Chinese PLA General Hospital 10
Not applicableStudy completedNCT03051425
What this trial is testing

Immune Benefits of Consumption of Dairy Yogurt in Elderly

Who this might be right for
Immune Deficiency
Yonsei University 200
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Not applicableUnknownNCT04867759
What this trial is testing

Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study

Who this might be right for
Repeated Implantation FailureICSI FailureuNatural Killer Cells
Tanta University 120
Early research (Phase 1)Study completedNCT03894579
What this trial is testing

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
NKGen Biotech, Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 7
Large-scale testing (Phase 3)UnknownNCT02631239
What this trial is testing

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Ruijin Hospital 256
Next Page